CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Short Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Short Term Provisions | ₹2,265 Cr | ₹1,793 Cr | ₹1,634 Cr | ₹1,303 Cr | ₹1,242 Cr |
What is the latest Short Term Provisions ratio of CIPLA ?
| Year | Short Term Provisions |
|---|---|
| Mar2026 | ₹2,265 Cr |
| Mar2025 | ₹1,793 Cr |
| Mar2024 | ₹1,634 Cr |
| Mar2023 | ₹1,303 Cr |
| Mar2022 | ₹1,242 Cr |
How is Short Term Provisions of CIPLA Trending?
| Years | Short Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,265 Cr | 26.28 | |
| Mar2025 | ₹1,793 Cr | 9.77 | |
| Mar2024 | ₹1,634 Cr | 25.36 | |
| Mar2023 | ₹1,303 Cr | 4.96 | |
| Mar2022 | ₹1,242 Cr | - | |
Compare Short Term Provisions of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹117,413.7 Cr | 2.7% | 2.5% | -4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,299.0 Cr | 0.5% | 1.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,207.0 Cr | -3.3% | -3.5% | 1.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,721.0 Cr | 4.5% | 2.6% | 42.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,876.0 Cr | 6.6% | 4.3% | 1.9% | Stock Analytics | |
| MANKIND PHARMA | ₹102,642.0 Cr | -2% | 2.7% | 7.5% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 2.7% |
2.5% |
-4% |
| SENSEX | -0.1% |
1% |
-5.7% |
You may also like the below Video Courses